Table 1.
Demographic and clinical characteristics of the patients.
| Gender | Age, years | BMI, kg/m2 | Underlying renal disease | RRF loss rate in predialysis, mL/min/month | RRF at dialysis initiation, mL/min | |
|---|---|---|---|---|---|---|
| Incremental PD (n = 17) |
9 F/8 M (53%) | 37 ± 13 | 23 ± 2 | 3 Alport | −0.97 ± 0.34 | 6.9 ± 1.1 |
| 2 FSGS | ||||||
| 2 VUR | ||||||
| 2 Ig AGNF | ||||||
| 1 SLE | ||||||
| 1 MC GNF | ||||||
| 1 undefined GNF | ||||||
| 1 DN | ||||||
| 1 vascular disease | ||||||
| 3 unknown | ||||||
|
| ||||||
| HD (n = 24) |
10 F/14 M (42%) | 43 ± 14 | 23 ± 2 | 3 Ig A GNF | −0.99 ± 0.48 | 6.8 ± 1.5 |
| 3 undefined GNF | ||||||
| 2 MN | ||||||
| 2 VUR | ||||||
| 2 HUS | ||||||
| 2 Alport | ||||||
| 1 ADPKD | ||||||
| 1 DN | ||||||
| 1 FSGS | ||||||
| 1 vasculitis | ||||||
| 6 unknown | ||||||
|
| ||||||
| P value | 0.7 | 0.1 | 0.8 | 0.48 | 0.4 | |
FSGS: focal segmental glomerulosclerosis; VUR: vescicoureteral reflux; SLE: systemic lupus erythematosus; MC GNF: mesangiocapillary glomerulonephritis; DN: diabetic nephropathy; MN: membranous nephropathy; HUS: haemolytic uremic syndrome; ADPKD: autosomal dominant polycystic kidney disease; GNF: glomerulonephritis; Ig A: immunoglobulin A.